Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1

Molecular Biology Reports

Volumn 38, Issue 2, 2011, Pages 1389-1397

  Potala, Sirisha ^a   Verma, Rama S ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

Diphtheria toxin; Fusion toxin; HN 1; HNSCC; Targeted therapy

Indexed keywords

CYTOTOXIC FACTOR; DIPHTHERIA TOXIN; PROTEIN HN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL VIABILITY; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOSOL; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG TARGETING; FLUORESCENCE SPECTROSCOPY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IC 50; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN SYNTHESIS INHIBITION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CLONING, MOLECULAR; DIPHTHERIA TOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAD AND NECK NEOPLASMS; HUMANS; INHIBITORY CONCENTRATION 50; LIGANDS; MUTAGENESIS, SITE-DIRECTED; OLIGOPEPTIDES; PLASMIDS;

EID: 79951581242     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0242-8     Document Type: Article

References (25)

1. D Chin GM Boyle S Porceddu DR Theile PG Parsons WB Coman 2006 Head and neck cancer: past, present and future Expert Rev Anticancer Ther 6 1111 1118 10.1586/14737140.6.7.1111 16831082 (Pubitemid 44203388)
2. X Wang W Sun J Bai L Ma Y Yu J Geng J Qi Z Shi S Fu 2009 Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma Mol Biol Rep 36 861 869 1:CAS:528:DC%2BD1MXjvFejs7Y%3D 10.1007/s11033-008-9256-x 18418730
3. Yalniz Z, Demokan S, Suoglu Y, Ulusan M, Dalay N (2010) Assessment of microsatellite instability in head and neck cancer using consensus markers. Mol Biol Rep. doi: 10.1007/s11033-010-0001-x
4. TY Seiwert EE Cohen 2005 State-of-the-art management of locally advanced head and neck cancer Br J Cancer 92 1341 1348 1:CAS:528:DC%2BD2MXjsVSjsb0%3D 10.1038/sj.bjc.6602510 15846296 (Pubitemid 40704997)
5. Z Mechl P Smilek R Cervena 2008 Current treatment strategies for patients with cancers of the head and neck Klin Onkol 21 45 52 1:STN:280: DC%2BD1M%2FktlGhtQ%3D%3D 19102211 (Pubitemid 351547965)
6. KA Gold HY Lee ES Kim 2009 Targeted therapies in squamous cell carcinoma of the head and neck Cancer 115 922 935 1:CAS:528:DC%2BD1MXjs1Kjur4%3D 10.1002/cncr.24123 19156911
7. S Potala SK Sahoo RS Verma 2008 Targeted therapy of cancer using diphtheria toxin-derived immunotoxins Drug Discov Today 13 807 1:CAS:528:DC%2BD1cXhtFaisb3K 10.1016/j.drudis.2008.06.017 18678276
8. MJ Bennett D Eisenberg 1994 Refined structure of monomeric diphtheria toxin at 2.3 Å resolution Protein Sci 3 1464 1475 1:CAS:528: DyaK2MXht1yntb4%3D 10.1002/pro.5560030912 7833808 (Pubitemid 24314465)
9. FD Hong GL Clayman 2000 Isolation of a peptide for targeted drug delivery into human head and neck solid tumors Cancer Res 60 6551 6556 1:CAS:528:DC%2BD3cXosl2isL0%3D 11118031
10. Potala S, Verma RS (2010) A novel fusion protein diphtheria toxin-stem cell factor (DT-SCF)-purification and characterization. Appl Biochem Biotechnol
11. X Zhao P Zhang Q Liu F He L Feng H Han 2009 Expression, purification and characterization of the extracellular domain of human Flt3 ligand in Escherichia coli Mol Biol Rep 37 5 2301 2307 10.1007/s11033-009-9724-y 19693697
12. JR Hawker Jr 2003 Chemiluminescence-based BrdU ELISA to measure DNA synthesis J Immunol Methods 274 77 82 1:CAS:528:DC%2BD3sXhsVCns7Y%3D 10.1016/S0022-1759(02)00437-4 12609534 (Pubitemid 36263044)
13. CB Saelinger PF Bonventre B Ivins D Straus 1976 Uptake of diphtheria toxin and its fragment A moiety by mammalian cells in culture Infect Immun 14 742 751 1:CAS:528:DyaE28Xlslanuro%3D 987022
14. RJ Kreitman 1999 Immunotoxins in cancer therapy Curr Opin Immunol 11 570 1:CAS:528:DyaK1MXmslahsb8%3D 10.1016/S0952-7915(99)00005-9 10508704 (Pubitemid 29462134)
15. E Olsen M Duvic A Frankel Y Kim A Martin E Vonderheid B Jegasothy G Wood M Gordon P Heald, et al. 2001 Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma J Clin Oncol 19 376 388 1:CAS:528:DC%2BD3MXhtVekt70%3D 11208829 (Pubitemid 32112849)
16. M Weaver DW Laske 2003 Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas J Neurooncol 65 3 10.1023/A:1026246500788 14649881 (Pubitemid 37441310)
17. A Dietz A Boehm C Mozet G Wichmann A Giannis 2008 Current aspects of targeted therapy in head and neck tumors Eur Arch Otorhinolaryngol 265 Suppl 1 S3 S12 10.1007/s00405-008-0697-6 18535834
18. M Duvic J Cather J Maize AE Frankel 1998 DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma Am J Hematol 58 87 90 1:STN:280:DyaK1c3ltVSnsg%3D%3D 10.1002/(SICI)1096-8652(199805) 58:1<87::AID-AJH18>3.0.CO;2-2 9590158 (Pubitemid 28213568)
19. S Choe MJ Bennett G Fujii PM Curmi KA Kantardjieff RJ Collier D Eisenberg 1992 The crystal structure of diphtheria toxin Nature 357 216 222 1:CAS:528:DyaK38Xkt1Wksr4%3D 10.1038/357216a0 1589020
20. D Liger JC vanderSpek C Gaillard C Cansier JR Murphy P Leboulch D Gillet 1997 Characterization and receptor specific toxicity of two diphtheria toxin-related interleukin-3 fusion proteins DAB389-mIL-3 and DAB389-(Gly4Ser)2-mIL-3 FEBS Lett 406 157 161 1:CAS:528:DyaK2sXisFKnuro%3D 10.1016/S0014-5793(97)00243-3 9109408 (Pubitemid 27156980)
21. AE Frankel J Ramage M Kiser R Alexander G Kucera MS Miller 2000 Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor Protein Eng 13 575 581 1:CAS:528:DC%2BD3cXmvFSntb4%3D 10.1093/protein/13.8.575 10964987
22. BG Van Ness JB Howard JW Bodley 1980 ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products J Biol Chem 255 10717 10720 7000782
23. J Thorburn AE Frankel A Thorburn 2003 Apoptosis by leukemia cell-targeted diphtheria toxin occurs via receptor-independent activation of Fas-associated death domain protein Clin Cancer Res 9 861 865 1:CAS:528:DC%2BD3sXhtVKktr0%3D 12576460 (Pubitemid 36182625)
24. A Thorburn J Thorburn AE Frankel 2004 Induction of apoptosis by tumor cell-targeted toxins Apoptosis 9 19 25 1:CAS:528:DC%2BD2cXjtFCrsw%3D%3D 10.1023/B:APPT.0000012118.95548.88 14739595 (Pubitemid 38270425)
25. H Horita AE Frankel A Thorburn 2008 Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms PLoS One 3 e3909 10.1371/journal.pone.0003909 19079542